New Street Research Raises Lam Research (NASDAQ:LRCX) Price Target to $235.00

Lam Research (NASDAQ:LRCX) had its target price increased by equities research analysts at New Street Research from $140.00 to $235.00 in a research note issued to investors on Tuesday,MarketScreener reports. The firm presently has a “neutral” rating on the semiconductor company’s stock. New Street Research’s price target would indicate a potential upside of 6.02% from the company’s current price.

Other equities analysts have also issued reports about the stock. The Goldman Sachs Group set a $262.00 price objective on shares of Lam Research and gave the company a “buy” rating in a research report on Thursday, January 29th. B. Riley Financial restated a “buy” rating on shares of Lam Research in a report on Thursday, January 15th. Oppenheimer reiterated an “outperform” rating and set a $265.00 target price on shares of Lam Research in a research note on Thursday, January 29th. Citigroup boosted their price target on Lam Research from $265.00 to $300.00 and gave the company a “buy” rating in a research note on Thursday, January 29th. Finally, TD Cowen increased their price objective on Lam Research from $170.00 to $290.00 and gave the stock a “buy” rating in a research report on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $245.35.

Lam Research Stock Up 3.7%

Shares of Lam Research stock traded up $8.00 during trading on Tuesday, reaching $221.66. The stock had a trading volume of 2,119,715 shares, compared to its average volume of 11,830,318. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. The stock has a fifty day moving average price of $227.18 and a two-hundred day moving average price of $183.68. The company has a market capitalization of $276.80 billion, a price-to-earnings ratio of 45.47, a P/E/G ratio of 2.15 and a beta of 1.77. Lam Research has a 52 week low of $56.32 and a 52 week high of $256.68.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. The company had revenue of $5.34 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business’s revenue was up 22.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Sell-side analysts predict that Lam Research will post 3.71 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Ava Harter sold 4,000 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $232.50, for a total value of $930,000.00. Following the completion of the transaction, the insider owned 54,705 shares of the company’s stock, valued at $12,718,912.50. This represents a 6.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Douglas R. Bettinger sold 50,057 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the sale, the chief financial officer owned 1,081,705 shares in the company, valued at $242,334,371.15. This represents a 4.42% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 130,886 shares of company stock worth $29,658,802 in the last three months. 0.31% of the stock is owned by corporate insiders.

Institutional Trading of Lam Research

A number of hedge funds have recently made changes to their positions in the company. PMV Capital Advisers LLC acquired a new stake in Lam Research during the 4th quarter worth approximately $25,000. Stance Capital LLC acquired a new position in Lam Research in the 3rd quarter valued at approximately $26,000. Bayban bought a new position in shares of Lam Research during the fourth quarter valued at $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research during the second quarter valued at $27,000. Finally, Triumph Capital Management acquired a new position in shares of Lam Research during the third quarter worth $27,000. 84.61% of the stock is owned by institutional investors and hedge funds.

Lam Research News Roundup

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Zacks highlights LRCX as a top long‑term holding based on its positive earnings outlook and inclusion on the Zacks Focus List — a signal that analysts expect continued outperformance. Why Lam Research (LRCX) is a Top Stock for the Long-Term
• Positive Sentiment: A Seeking Alpha piece argues Lam is “poised for growth,” noting it’s a critical supplier for AI-era chipmaking, showing expanding capex/customer demand, improved operating margins and tighter working‑capital metrics — supportive for revenue and margin expansion. Lam Research: Poised For Growth, Looking Past Short-Term Turbulence
• Positive Sentiment: Coverage noting strong Q4 demand for Lam’s tools (recap/analysis) reinforces the earnings beat narrative and underpins near‑term revenue momentum heading into the next report. Strong Demand Lifted Lam Research Corporation (LRCX) in Q4
• Neutral Sentiment: Macro market strength (risk‑on) lifted tech stocks broadly, providing tailwinds to LRCX’s move higher today; this is market‑driven rather than company‑specific. Stocks Rally as President Trump Considers Ending Iran War
• Neutral Sentiment: Analysts and previews setting expectations for Lam’s next quarterly report outline key metrics investors should watch (bookings, end‑market mix, margin trajectory) — helpful but not new catalyst by itself. What to Expect From Lam Research’s Next Quarterly Earnings Report
• Neutral Sentiment: Industry items — Applied Materials expanding AI‑centric R&D and AMD Foundation investing in workforce pipelines — are mixed for Lam: they validate secular AI demand but also signal competition and the need for ongoing product leadership. AMAT Deepens its AI-Centric Product Expertise: Will it Deliver Growth? The AMD Foundation Joins Last Mile Education Fund’s National Semiconductor Coalition
• Negative Sentiment: Geopolitical-driven “helium shock” stories raise a tangible operational risk: constrained helium and critical gases from the Middle East could disrupt Lam’s ability to supply and service wafer‑fab tools, introducing upside risk to costs and delivery timelines. Investors should monitor supply‑chain updates and customer impact disclosures. Middle East Helium Shock Puts Lam Research Supply Chain In Focus

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.